SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -53.93 Million SEK | -15.98% |
| 2022 | -46.44 Million SEK | -9.52% |
| 2021 | -42.41 Million SEK | -25.04% |
| 2020 | -33.91 Million SEK | 13.57% |
| 2019 | -39.24 Million SEK | 10.86% |
| 2018 | -44.01 Million SEK | -3.74% |
| 2017 | -42.43 Million SEK | 20.08% |
| 2016 | -53.09 Million SEK | -26.49% |
| 2015 | -41.97 Million SEK | -7.93% |
| 2014 | -38.89 Million SEK | -11.32% |
| 2013 | -34.93 Million SEK | -4.19% |
| 2012 | -33.53 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -14.57 Million SEK | -3.06% |
| 2024 Q1 | -14.26 Million SEK | 14.6% |
| 2023 Q2 | -13.82 Million SEK | -28.2% |
| 2023 FY | -53.87 Million SEK | -15.98% |
| 2023 Q4 | -16.7 Million SEK | -31.16% |
| 2023 Q3 | -12.73 Million SEK | 7.88% |
| 2023 Q1 | -10.78 Million SEK | -140.29% |
| 2022 Q1 | -9.69 Million SEK | 29.77% |
| 2022 Q4 | 26.76 Million SEK | 335.31% |
| 2022 FY | -46.44 Million SEK | -9.52% |
| 2022 Q2 | -11.71 Million SEK | -20.79% |
| 2022 Q3 | -11.37 Million SEK | 2.89% |
| 2021 Q1 | -8.11 Million SEK | 17.17% |
| 2021 FY | -42.41 Million SEK | -25.04% |
| 2021 Q4 | -13.8 Million SEK | -60.86% |
| 2021 Q3 | -8.58 Million SEK | 22.7% |
| 2021 Q2 | -11.1 Million SEK | -36.9% |
| 2020 Q1 | -8.86 Million SEK | 12.49% |
| 2020 FY | -33.91 Million SEK | 13.57% |
| 2020 Q4 | -9.79 Million SEK | -33.75% |
| 2020 Q3 | -7.32 Million SEK | 16.71% |
| 2020 Q2 | -8.79 Million SEK | 0.87% |
| 2019 FY | -39.24 Million SEK | 10.86% |
| 2019 Q4 | -10.13 Million SEK | -3.39% |
| 2019 Q3 | -9.8 Million SEK | 7.06% |
| 2019 Q2 | -10.54 Million SEK | -18.15% |
| 2019 Q1 | -8.92 Million SEK | 22.23% |
| 2018 Q2 | -10.23 Million SEK | -6.77% |
| 2018 Q4 | -11.47 Million SEK | 9.74% |
| 2018 Q1 | -9.59 Million SEK | 6.88% |
| 2018 FY | -44.01 Million SEK | -3.74% |
| 2018 Q3 | -12.71 Million SEK | -24.17% |
| 2017 FY | -42.43 Million SEK | 20.08% |
| 2017 Q2 | -11.71 Million SEK | -0.92% |
| 2017 Q4 | -10.29 Million SEK | -16.97% |
| 2017 Q1 | -11.61 Million SEK | 20.55% |
| 2017 Q3 | -8.8 Million SEK | 24.86% |
| 2016 Q1 | -11.6 Million SEK | -4.03% |
| 2016 Q3 | -12.4 Million SEK | 14.27% |
| 2016 Q2 | -14.47 Million SEK | -24.75% |
| 2016 Q4 | -14.61 Million SEK | -17.79% |
| 2016 FY | -53.09 Million SEK | -26.49% |
| 2015 Q3 | -10.28 Million SEK | 9.52% |
| 2015 Q2 | -11.36 Million SEK | -24.01% |
| 2015 Q1 | -9.16 Million SEK | 9.44% |
| 2015 FY | -41.97 Million SEK | -7.93% |
| 2015 Q4 | -11.15 Million SEK | -8.41% |
| 2014 Q3 | -7.98 Million SEK | 31.55% |
| 2014 Q4 | -10.12 Million SEK | -26.79% |
| 2014 Q2 | -11.66 Million SEK | -29.45% |
| 2014 Q1 | -9.01 Million SEK | 0.0% |
| 2014 FY | -38.89 Million SEK | -11.32% |
| 2013 FY | -34.93 Million SEK | -4.19% |
| 2012 FY | -33.53 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 30.449% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 117.944% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 117.944% |
| Arcoma AB | 4.66 Million SEK | 1257.489% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 59.116% |
| BICO Group AB (publ) | -618.3 Million SEK | 91.276% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | 237.354% |
| CellaVision AB (publ) | 167.05 Million SEK | 132.289% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 18.191% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | -82.402% |
| C-Rad AB (publ) | 44.24 Million SEK | 221.913% |
| Duearity AB (publ) | -25.76 Million SEK | -109.366% |
| Dignitana AB (publ) | -15.02 Million SEK | -258.971% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 43.102% |
| Getinge AB (publ) | 3.81 Billion SEK | 101.414% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 21.195% |
| Iconovo AB (publ) | -45.77 Million SEK | -17.831% |
| Integrum AB (publ) | 6.51 Million SEK | 928.258% |
| Luxbright AB (publ) | -25.8 Million SEK | -109.03% |
| Mentice AB (publ) | -679 Thousand SEK | -7843.888% |
| OssDsign AB (publ) | -91.95 Million SEK | 41.343% |
| Paxman AB (publ) | 12.61 Million SEK | 527.443% |
| Promimic AB (publ) | -9.11 Million SEK | -491.566% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 68.026% |
| ScandiDos AB (publ) | -13.48 Million SEK | -300.052% |
| Sectra AB (publ) | 518.49 Million SEK | 110.403% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 17.709% |
| Senzime AB (publ) | -133.74 Million SEK | 59.67% |
| SpectraCure AB (publ) | -21.35 Million SEK | -152.63% |
| Stille AB | 44.95 Million SEK | 219.992% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 98.497% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | 240.079% |